Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Aul

Showing results (11-20 of 177) with videos related to

Pageof 18
Sort By:
Der Internist|December 22, 1998
[Myelodysplastic syndromes]C Aul, U Germing
Leukemia Research|January 1, 1992
The role of low-dose chemotherapy in myelodysplastic syndromesC Aul, N Gattermann
Haematology and Blood Transfusion|January 1, 1990
Treatment of advanced myelodysplastic syndromes: trend toward more aggressive chemotherapy?C Aul, W Schneider
Aktuelle Urologie|September 16, 2005
[Anti-angiogenic therapy of a renal angiomyolipoma in a seriously disabled patient suffering from multiple sclerosis]M Schroeder, C Aul
Zeitschrift Fur Gastroenterologie|October 1, 1988
[Alcohol-induced disorders of the hematopoietic system]R E Scharf, C Aul
International Journal of Oncology|May 10, 2011
Expression of cd34 and p-glycoprotein - prognostic-significance in primary myelodysplastic syndromesV Runde, U Germing, C Aul
Leukemia|December 1, 1993
Is acquired idiopathic sideroblastic anemia (AISA) a disorder of mitochondrial DNA?N Gattermann, C Aul, W Schneider
Leukemia & Lymphoma|January 1, 1995
Epidemiological and etiological aspects of myelodysplastic syndromesC Aul, N Gattermann, W Schneider
European Journal of Haematology|January 1, 1991
Treatment of advanced myelodysplastic syndromes with recombinant interferon-alpha 2bC Aul, N Gattermann, W Schneider
British Journal of Haematology|October 1, 1992
Age-related incidence and other epidemiological aspects of myelodysplastic syndromesC Aul, N Gattermann, W Schneider
Pageof 18

Showing results (11-20 of 177) with videos related to

Sort By:
Pageof 18
Der Internist|December 22, 1998
[Myelodysplastic syndromes]C Aul, U Germing
Leukemia Research|January 1, 1992
The role of low-dose chemotherapy in myelodysplastic syndromesC Aul, N Gattermann
Haematology and Blood Transfusion|January 1, 1990
Treatment of advanced myelodysplastic syndromes: trend toward more aggressive chemotherapy?C Aul, W Schneider
Aktuelle Urologie|September 16, 2005
[Anti-angiogenic therapy of a renal angiomyolipoma in a seriously disabled patient suffering from multiple sclerosis]M Schroeder, C Aul
Zeitschrift Fur Gastroenterologie|October 1, 1988
[Alcohol-induced disorders of the hematopoietic system]R E Scharf, C Aul
International Journal of Oncology|May 10, 2011
Expression of cd34 and p-glycoprotein - prognostic-significance in primary myelodysplastic syndromesV Runde, U Germing, C Aul
Leukemia|December 1, 1993
Is acquired idiopathic sideroblastic anemia (AISA) a disorder of mitochondrial DNA?N Gattermann, C Aul, W Schneider
Leukemia & Lymphoma|January 1, 1995
Epidemiological and etiological aspects of myelodysplastic syndromesC Aul, N Gattermann, W Schneider
European Journal of Haematology|January 1, 1991
Treatment of advanced myelodysplastic syndromes with recombinant interferon-alpha 2bC Aul, N Gattermann, W Schneider
British Journal of Haematology|October 1, 1992
Age-related incidence and other epidemiological aspects of myelodysplastic syndromesC Aul, N Gattermann, W Schneider
Pageof 18